Evidence map›Paper›PMID 23527013›Full record

Trial reportPloS one2013

Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial.

Arash Hossein-nezhad, Avrum Spira, Michael F Holick

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 124 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01696409 completednot on this map

The Effect of Vitamin D on Measures of Bone Health and Gene Expression

TypeobservationalSponsorBoston UniversityRan2009 to 2012Enrolled11ConditionsVitamin D DeficiencyArms400 IU vitamin D3, 2000 IU vitamin D3
NCT02954549 nacompletednot on this mapstarted 2016, after this paper: background citation

Genomics of Vitamin D Supplementation and Warfighter Nutritional Resilience

TypeinterventionalSponsorMadigan Army Medical CenterRan2016 to 2018Enrolled131ConditionsVitamin D Deficiency DiseaseArmsVitamin D3
3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Vitamins DFrontiers in immunology · 2022
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Vitamin DBMC cardiovascular disorders · 2017
    Trial
  10. Trial
  11. Early pregnancy vitamin D status and risk of preeclampsia.The Journal of clinical investigation · 2016
    Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arash Hossein-nezhadDepartment of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin and Bone Research Laboratory, Boston University Medical Center, Boston, Massachusetts, United States of America.
Avrum Spira
Michael F Holick

Funding

NCRR NIH HHS UL-1-RR-25711
6 · The paper itself

Abstract

backgroundAlthough there have been numerous observations of vitamin D deficiency and its links to chronic diseases, no studies have reported on how vitamin D status and vitamin D3 supplementation affects broad gene expression in humans. The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults. (Trial registration: ClinicalTrials.gov NCT01696409). METHODS AND

findingsA randomized, double-blind, single center pilot trial was conducted for comparing vitamin D supplementation with either 400 IUs (n = 3) or 2000 IUs (n = 5) vitamin D3 daily for 2 months on broad gene expression in the white blood cells collected from 8 healthy adults in the winter. Microarrays of the 16 buffy coats from eight subjects passed the quality control filters and normalized with the RMA method. Vitamin D3 supplementation that improved serum 25-hydroxyvitamin D concentrations was associated with at least a 1.5 fold alteration in the expression of 291 genes. There was a significant difference in the expression of 66 genes between subjects at baseline with vitamin D deficiency (25(OH)D<20 ng/ml) and subjects with a 25(OH)D>20 ng/ml. After vitamin D3 supplementation gene expression of these 66 genes was similar for both groups. Seventeen vitamin D-regulated genes with new candidate vitamin D response elements including TRIM27, CD83, COPB2, YRNA and CETN3 which have been shown to be important for transcriptional regulation, immune function, response to stress and DNA repair were identified. CONCLUSION/SIGNIFICANCE: Our data suggest that any improvement in vitamin D status will significantly affect expression of genes that have a wide variety of biologic functions of more than 160 pathways linked to cancer, autoimmune disorders and cardiovascular disease with have been associated with vitamin D deficiency. This study reveals for the first time molecular finger prints that help explain the nonskeletal health benefits of vitamin D.

trial registrationClinicalTrials.gov NCT01696409.

Indexed as

AdultCholecalciferolDose-Response Relationship, DrugDouble-Blind MethodFemaleGene ExpressionHumansLeukocytesMaleOligonucleotide Array Sequence AnalysisVitamin DVitamin D DeficiencyVitamin D Response ElementYoung Adult25-hydroxyvitamin DCholecalciferolVitamin D

Identifiers

PMID23527013
PMCPMC3604145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.